Maplelane Capital’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$55.3M Buy
124,000
+1,000
+0.8% +$470K 1% 31
2026
Q1
$48.8M Buy
123,000
+71,500
+139% +$32.3M 1.75% 19
2025
Q4
$24.2M Buy
51,500
+32,500
+171% +$14.4M 0.85% 42
2025
Q3
$9.37M Buy
+19,000
New +$10.7M 0.22% 77
2025
Q2
Sell
-25,000
Closed -$10.7M 107
2025
Q1
$10.7M Buy
25,000
+6,203
+33% +$3.01M 0.44% 54
2024
Q4
$9.12M Buy
+18,797
New +$9.83M 0.26% 76

Other funds holding SNPS

Maplelane Capital's SNPS Position: Q2 2026 in Review

Maplelane Capital increased its Synopsys (SNPS) stake by 0.81% in Q2 2026, buying an estimated $470K and bringing the position to 124,000 shares worth $55.3M. The position accounts for 1% of the portfolio, ranked #31.

Maplelane Capital first reported a position in SNPS in Q4 2024 and has held it in 6 quarters since. 1,444 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.

  • Maplelane Capital held 124,000 shares of Synopsys worth $55.3M as of Q2 2026.
  • Maplelane Capital bought 1,000 Synopsys shares in Q2 2026, an estimated $470K.
  • Synopsys made up 1% of Maplelane Capital's portfolio in Q2 2026, its #31 holding.
  • Maplelane Capital first reported a position in Synopsys in Q4 2024 and has held it in 6 quarters since.
  • 1,444 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.

Based on Maplelane Capital's 13F filing for Q2 2026, filed 13 Aug 2026.